148 related articles for article (PubMed ID: 16827800)
1. Alterations in ATR in nasal NK/T-cell lymphoma and chronic active Epstein-Barr virus infection.
Liu A; Takakuwa T; Luo WJ; Fujita S; Aozasa K
Cancer Sci; 2006 Jul; 97(7):605-10. PubMed ID: 16827800
[TBL] [Abstract][Full Text] [Related]
2. ATR alterations in Hodgkin's lymphoma.
Liu A; Takakuwa T; Fujita S; Luo WJ; Tresnasari K; Van den Berg A; Poppema S; Aozasa K
Oncol Rep; 2008 Apr; 19(4):999-1005. PubMed ID: 18357388
[TBL] [Abstract][Full Text] [Related]
3. Gene mutation analysis of sinonasal lymphomas in Indonesia.
Kurniawan AN; Hongyo T; Hardjolukito ES; Ham MF; Takakuwa T; Kodariah R; Hoshida Y; Nomura T; Aozasa K
Oncol Rep; 2006 May; 15(5):1257-63. PubMed ID: 16596195
[TBL] [Abstract][Full Text] [Related]
4. Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients.
Nagato T; Kobayashi H; Kishibe K; Takahara M; Ogino T; Ishii H; Oikawa K; Aoki N; Sato K; Kimura S; Shimizu N; Tateno M; Harabuchi Y
Clin Cancer Res; 2005 Dec; 11(23):8250-7. PubMed ID: 16322282
[TBL] [Abstract][Full Text] [Related]
5. Expression of cell adhesion molecules and chemokine receptors: angioinvasiveness in nasal NK/T-cell lymphoma.
Liu A; Nakatsuka S; Yang WI; Kojya S; Aozasa K
Oncol Rep; 2005 Apr; 13(4):613-20. PubMed ID: 15756432
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional profiling of Epstein-Barr virus (EBV) genes and host cellular genes in nasal NK/T-cell lymphoma and chronic active EBV infection.
Zhang Y; Ohyashiki JH; Takaku T; Shimizu N; Ohyashiki K
Br J Cancer; 2006 Feb; 94(4):599-608. PubMed ID: 16449999
[TBL] [Abstract][Full Text] [Related]
7. Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection.
Kimura H; Hoshino Y; Hara S; Sugaya N; Kawada J; Shibata Y; Kojima S; Nagasaka T; Kuzushima K; Morishima T
J Infect Dis; 2005 Feb; 191(4):531-9. PubMed ID: 15655776
[TBL] [Abstract][Full Text] [Related]
8. [Extranodal nasal type NK/T-cell lymphoma: the expression of Epstein-Barr virus latent membrane protein 1 and its significance of prognosis].
Zhao S; Liu WP; Zhang WY; Li GD
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 May; 36(3):338-40. PubMed ID: 15931862
[TBL] [Abstract][Full Text] [Related]
9. Extranodal type T/NK-cell lymphoma with an atypical clinical presentation.
Aydin GB; Akyuz C; Talim B; Evans SE; Sahin S; Sari N; Tabanlioglu D; Ozen S; Cağlar M; Büyükpamukçu M
Pediatr Hematol Oncol; 2007 Jun; 24(4):291-9. PubMed ID: 17613872
[TBL] [Abstract][Full Text] [Related]
10. Nasal natural killer/T cell lymphoma: case report with molecular biologic examination on Epstein-Barr virus and cell cycle regulatory p16, cyclin D1, Rb, and p53 genes.
Baba Y; Tsukuda M; Kagata H; Kato Y; Nakatani Y; Ehara M; Nagashima Y; Taki A; Aoki I
J Otolaryngol; 2000 Apr; 29(2):121-5. PubMed ID: 10819114
[No Abstract] [Full Text] [Related]
11. Coexpression of CD40 and CD40 ligand in Epstein-Barr virus-infected T and NK cells and their role in cell survival.
Imadome K; Shimizu N; Arai A; Miura O; Watanabe K; Nakamura H; Nonoyama S; Yamamoto K; Fujiwara S
J Infect Dis; 2005 Oct; 192(8):1340-8. PubMed ID: 16170750
[TBL] [Abstract][Full Text] [Related]
12. Presence of natural killer-cell clones with variable proliferative capacity in chronic active Epstein-Barr virus infection.
Nagata H; Numata T; Konno A; Mikata I; Kurasawa K; Hara S; Nishimura M; Yamamoto K; Shimizu N
Pathol Int; 2001 Oct; 51(10):778-85. PubMed ID: 11881730
[TBL] [Abstract][Full Text] [Related]
13. [Nasal NK/T lymphoma. A case report].
Ladeb S; Gaulard P; Ben Othmen T; Abd Alsamad I; Delfau-Larue MH; Abdelkefi A; Torjmen L; Ben Abdeladhim A
Ann Pathol; 2003 Apr; 23(2):149-52. PubMed ID: 12843969
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
[TBL] [Abstract][Full Text] [Related]
15. Natural killer cell-type body cavity lymphoma following chronic active Epstein-Barr virus infection.
Ogata M; Imamura T; Mizunoe S; Ohtsuka E; Kikuchi H; Nasu M
Am J Hematol; 2003 Jun; 73(2):126-30. PubMed ID: 12749015
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?
Kimura H
Rev Med Virol; 2006; 16(4):251-61. PubMed ID: 16791843
[TBL] [Abstract][Full Text] [Related]
17. Alterations of DNA damage-response genes ATM and ATR in pyothorax-associated lymphoma.
Liu A; Takakuwa T; Fujita S; Ham MF; Luo WJ; Daibata M; Aozasa K
Lab Invest; 2005 Mar; 85(3):436-46. PubMed ID: 15696190
[TBL] [Abstract][Full Text] [Related]
18. Human cancer cells require ATR for cell cycle progression following exposure to ionizing radiation.
Hurley PJ; Wilsker D; Bunz F
Oncogene; 2007 Apr; 26(18):2535-42. PubMed ID: 17043640
[TBL] [Abstract][Full Text] [Related]
19. Nodal T/NK-cell lymphoma of nasal type: a clinicopathological study of six cases.
Takahashi E; Asano N; Li C; Tanaka T; Shimada K; Shimada S; Yoshino T; Kojima M; Hara K; Eimoto T; Nakamura S
Histopathology; 2008 Apr; 52(5):585-96. PubMed ID: 18370955
[TBL] [Abstract][Full Text] [Related]
20. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
